Table 2.
Breakdown of death and hospitalization for incident heart failure by study groupa
Outcome types | Non-ischaemic LGE |
Ischaemic LGE |
Total | ||
---|---|---|---|---|---|
No LGE | Minor non-ischaemic LGE | Major non-ischaemic LGE | Myocardial infarction LGE | ||
Death | 45/397 | 30/238 | 8/54 | 32/211 | 115/900 |
11.3% | 12.6% | 14.8% | 15.2% | 12.8% | |
Hospitalization for incident heart failure | 15/397 | 17/238 | 13/54 | 32/211 | 77/900 |
3.8% | 7.1% | 24.1% | 15.2% | 8.6% | |
Primary study outcome | 60/397 | 47/238 | 21/54 | 64/211 | 192/900 |
15.1% | 19.8% | 38.9% | 30.3% | 21.3% |
LGE, late gadolinium enhancement.
Results are listed as number of events in study group/study group size and percentage. Note that events summarized in this table represent the first event. Of the 77 participants with heart failure as their endpoint, 32 eventually died. These 32 deaths are not in the table since the Kaplan–Meier method censors a patient from further analysis after meeting the study endpoint. However, the high mortality of the adjudicated heart failure endpoint is an indication that this was a relevant metric of adverse subject outcome.